AT352756B - Verfahren zur verstaerkung der antigenen wirkung des schwangerschaftsspezifischen beta1- glykoproteins - Google Patents

Verfahren zur verstaerkung der antigenen wirkung des schwangerschaftsspezifischen beta1- glykoproteins

Info

Publication number
AT352756B
AT352756B AT731176A AT731176A AT352756B AT 352756 B AT352756 B AT 352756B AT 731176 A AT731176 A AT 731176A AT 731176 A AT731176 A AT 731176A AT 352756 B AT352756 B AT 352756B
Authority
AT
Austria
Prior art keywords
pregnancy
glycoprotein
enhancing
beta1
antigenic effects
Prior art date
Application number
AT731176A
Other languages
English (en)
Other versions
ATA731176A (de
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of ATA731176A publication Critical patent/ATA731176A/de
Application granted granted Critical
Publication of AT352756B publication Critical patent/AT352756B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT731176A 1975-10-02 1976-10-01 Verfahren zur verstaerkung der antigenen wirkung des schwangerschaftsspezifischen beta1- glykoproteins AT352756B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2543994A DE2543994C3 (de) 1975-10-02 1975-10-02 Proteinmodifizierte Verbindungen des schwangerschaftsspezifischen ß, -Glykoproteins und deren Verwendung als Bestandteil von immunisierenden Mitteln

Publications (2)

Publication Number Publication Date
ATA731176A ATA731176A (de) 1979-03-15
AT352756B true AT352756B (de) 1979-10-10

Family

ID=5958064

Family Applications (1)

Application Number Title Priority Date Filing Date
AT731176A AT352756B (de) 1975-10-02 1976-10-01 Verfahren zur verstaerkung der antigenen wirkung des schwangerschaftsspezifischen beta1- glykoproteins

Country Status (16)

Country Link
JP (1) JPS5290613A (de)
AT (1) AT352756B (de)
AU (1) AU511175B2 (de)
BE (1) BE846928A (de)
DE (1) DE2543994C3 (de)
DK (1) DK444576A (de)
FI (1) FI762790A (de)
FR (1) FR2326203A1 (de)
GB (1) GB1560633A (de)
IL (1) IL50589A (de)
IT (1) IT1070582B (de)
LU (1) LU75913A1 (de)
NL (1) NL7610688A (de)
NO (1) NO763361L (de)
NZ (1) NZ182193A (de)
SE (1) SE7610892L (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191533A (en) * 1971-09-29 1980-03-04 Behringwerke Aktiengesellschaft Pregnancy-specific β1 -glycoprotein and process for isolating it
DE3525926A1 (de) 1985-07-19 1987-01-29 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung von pankreas-alpha-amylase
WO2013123423A1 (en) * 2012-02-17 2013-08-22 Castech Laboratories, Llc Purification method

Also Published As

Publication number Publication date
AU511175B2 (en) 1980-07-31
DK444576A (da) 1977-04-03
IT1070582B (it) 1985-03-29
NZ182193A (en) 1979-03-28
SE7610892L (sv) 1977-04-03
LU75913A1 (de) 1977-05-11
DE2543994B2 (de) 1979-02-15
NL7610688A (nl) 1977-04-05
BE846928A (fr) 1977-04-04
GB1560633A (en) 1980-02-06
JPS5290613A (en) 1977-07-30
IL50589A0 (en) 1976-11-30
ATA731176A (de) 1979-03-15
IL50589A (en) 1980-10-26
FR2326203A1 (fr) 1977-04-29
DE2543994C3 (de) 1979-10-11
NO763361L (de) 1977-04-05
FR2326203B1 (de) 1980-10-31
AU1831876A (en) 1978-04-06
DE2543994A1 (de) 1977-04-07
FI762790A (de) 1977-04-03

Similar Documents

Publication Publication Date Title
DD130857A5 (de) Verfahren zur herstellung von n-phosphonomethylglycintriestern
DD128812A5 (de) Verfahren zur herstellung von chinazolonderivaten
PT65443B (de) Verfahren zur herstellung von tertiaren aliphatischen aminen
DD128782A5 (de) Verfahren zur herstellung von n-alkyldiphenylaminen
AT351187B (de) Verfahren zur herstellung von 7-dehydrochol- esterinderivaten
AT344147B (de) Verfahren zur herstellung von acylcyaniden
DD130576A5 (de) Verfahren zur herstellung von derivaten von 5-hydroxy-chininzarinchinon
ATA314576A (de) Verfahren zur herstellung von 4-nideralkyl-5- cyano-oxazolen
DD127765A1 (de) Verfahren zur herstellung von expansivzement
ATA662376A (de) Verfahren zur herstellung von terpolymerisaten
AT349032B (de) Verfahren zur herstellung von 4-alkyl-thiosemicarbaziden
AT352756B (de) Verfahren zur verstaerkung der antigenen wirkung des schwangerschaftsspezifischen beta1- glykoproteins
DD132435A5 (de) Verfahren zur herstellung von indolochinolizinen
AT345297B (de) Verfahren zur substitution von chloratomen des cyanurchlorids
ATA44576A (de) Verfahren zur herstellung von n- (alfa-alkoxyathyl)-carbonsaureamiden
DD131561A5 (de) Verfahren zur herstellung von 5-androsten-derivaten
AT334909B (de) Verfahren zur herstellung von substituierten thiocarbaminsaure-s-alkylestern
AT336596B (de) Verfahren zur herstellung von 1-aminoanthrachinon
DD122961A5 (de) Verfahren zur herstellung von diphenylaether-derivaten
AT344920B (de) Verfahren zur anreicherung des schwangerschaftsspezifischen beta1-glykoproteins
DD122977A5 (de) Verfahren zur herstellung von thieno-pyridin-derivaten
AT343619B (de) Verfahren zur herstellung von propargylaminen
AT345782B (de) Verfahren zur herstellung von n-phenyl-5-chlor- 2-nitranilin
AT353954B (de) Verfahren zur herstellung von 7- methoxycephalosporinderivaten
AT344323B (de) Verfahren zur herstellung von anhydro-5-hydroxytetracyclin

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee